{
      "ptx_code": "PTX041",
      "chem_name": "Clofibric acid",
      "casrn": "882-09-7",
      "dtxsid": "DTXSID1040661",
      "smiles": "CC(C)(OC1=CC=C(Cl)C=C1)C(O)=O",
      "inchikey": "TXCGAZHTZHNUAI-UHFFFAOYSA-N",
      "label": "PTX041 | Clofibric acid",
      "pubchem_cid": "2797",
      "drugbank_id": "",
      "use_class": "Endogenous",
      "tox_class": "Hepatotoxicity; Genotoxicity; Nephrotoxicity",
      "formula": "C10H11ClO3",
      "chem_name_user": "clofibric acid",
      "mw_g_mol": "214.65",
      "solubility_h2o_mol_liter": "3.69e-03",
      "source_solubility_h2o": "COMPTOX",
      "henry_coefficient_atm_m3_mol": "1.66e-09",
      "source_henry": "COMPTOX (Opera)",
      "log_kaw_kh_rt": "7.17",
      "source_kaw": "Comptox",
      "pka_acid": "2.50",
      "pka_base": "",
      "source_pka": "Drillia et al. 2005",
      "log_kow_liter_liter": "2.57",
      "source_kow": "experimental Hansch,C et al. (1995)",
      "log_dlipw_ph74_liter_liter": "1.83",
      "source_dlipw": "LSERD for neutral and COSMO for charged",
      "freely_dissolved_fraction": "0.58",
      "density_kg_liter": "1.29",
      "source_density": "COMPTOX",
      "boiling_point": "324.00",
      "source_boiling_point": "CompTox (Biosynth (Chemical company)",
      "melting_point": "118.0; 118.5; 119.5; 120.0; 121.0",
      "source_melting_point": "CompTox (LKT Labs (Chemical company; Jean-Claude Bradley Open Melting Point Dataset; Alfa Aesar (Chemical company; Jean-Claude Bradley Open Melting Point Dataset; Biosynth (Chemical company)",
      "vapor_pressure": "",
      "source_vapor_pressure": "",
      "baseline_drerio": "2560.00",
      "baseline_dmagna": "1060.00",
      "baseline_celegans": "2299.64",
      "baseline_xlaevis": "586.09",
      "baseline_dmelanogaster": "9385.16",
      "baseline_cells": "6.65e-04",
      "baseline_cells_generic_micromole_liter_free_ec10": "3.85e-04",
      "moa_drugbank": "",
      "protein_binding": "",
      "moa_t3db": "",
      "aop": [
            {
                  "AOP_id": 6,
                  "AOP_name": "Antagonist binding to PPAR\u03b1 leading to body-weight loss "
            },
            {
                  "AOP_id": 61,
                  "AOP_name": "NFE2L2/FXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 72,
                  "AOP_name": "Epigenetic modification of PPARG leading to adipogenesis "
            },
            {
                  "AOP_id": 131,
                  "AOP_name": "Aryl hydrocarbon receptor activation leading to uroporphyria "
            }
      ],
      "targets": []
}